2020

• September 2nd Press release: our recent publication in Journal of Investigative Dermatology where we identified non-canonical EphA2 signaling is a driver of the BRAF inhibitor-resistant melanoma

• January 10th  Press release: our recent publication in Clinical Cancer Research where we analyzed protein expression markers in CSF from patients with leptomeningeal disease

2019

• October 8th Press release: using an adaptive dosing schedule for BRAFi therapy prolongs drug sensitivity in melanoma by maintaining diverse tumor cell populations

• July 8th Press release: our publication in Clinical Cancer Research where preclinical studies reveal the impact of HDAC inhibitors in uveal melanoma